Actively Recruiting
Phase 2 Study of Group ACYW135 Meningococcal Conjugate Vaccine Safety and Immune Response in Healthy Infants Aged 3 to 5 Months
Led by Sinovac Biotech Co., Ltd · Updated on 2026-08-10
880
Participants Needed
2
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating an investigational group ACYW135 meningococcal conjugate vaccine in healthy children aged 3 to 5 months. The study aims to compare the immune response and safety of this new vaccine with a licensed control vaccine during the primary vaccination series and after a booster dose given at 12 months of age. The trial also examines how well the immune protection lasts up to 12 months and assesses any adverse effects. Participants are randomly assigned to receive either three doses of the investigational vaccine or the control vaccine at 0, 1, and 2 months during the primary immunization phase. At 12 months, they receive a booster dose of the same vaccine assigned to their group. Blood samples are collected before vaccination, 30 days after the primary series, before the booster, and 30 days after the booster. Participants are monitored closely for immediate and delayed side effects using observation periods and diary cards. Throughout the study, participants undergo safety checks including observation for 30 minutes after each dose and recording of any local or systemic reactions for 7 days, plus unsolicited events for 30 days. Serious adverse events are followed for at least 6 months after the last dose. The main outcomes measured are immune responses to meningococcal bacteria serogroups A, C, Y, and W135, including antibody levels and seroconversion rates. The study plans to enroll 880 participants, with a total participation duration extending to at least 18 months.
CONDITIONS
Brief Title
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
Research Team
Y
Yi Mo
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here